Patent intelligence · DE
DE 202010004750
Pharmazeutische oder/und kosmetische Zusammensetzung zur Behandlung der Haut
Pharmazeutische oder/und kosmetische Zusammensetzung zur Behandlung der Haut
Patent details — DE 202010004750
- Jurisdiction
- DE
- Status
- granted
- Grant date
- Oct 11, 2011
- Expiration
- Oct 6, 2031
- Applicant
- BIOFRONTERA BIOSCIENCE GMBH [DE]
- CPC classes
- A61K 8/ 97 A I, A61K 36/ 29 A I, A61K 36/ 54 A I, A61K 36/ 68 A I
Quick answer
DE 202010004750 (Pharmazeutische oder/und kosmetische Zusammensetzung zur Behandlung der Haut) is held by BIOFRONTERA BIOSCIENCE GMBH [DE]. Status: granted. Granted Oct 11, 2011. Expires Oct 6, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BIOFRONTERA BIOSCIENCE GMBH [DE]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 8/ 97 A I, A61K 36/ 29 A I, A61K 36/ 54 A I, A61K 36/ 68 A I, A61K 36/ 87 A I, A61K 36/ 185 A I
More from BIOFRONTERA BIOSCIENCE GMBH [DE]
Related pharmaceutical patents in our USPTO index.
-
US 20260108463
NANOEMULSION FORMULATION WITH IMPROVED TACROLIMUS STABILITY AND SKIN PENETRATION
granted -
US 2024335360
PRESSURIZED NANOEMULSION
granted -
WO 2024209065
NANOÉMULSION SOUS PRESSION
granted -
WO 2024209064
NANOÉMULSION SANS PROPYLÈNE GLYCOL
granted -
US 2024335380
NANOEMULSION WITHOUT PROPYLENE GLYCOL
granted -
US 2021315993
PHOTODYNAMIC THERAPY COMPRISING TWO LIGHT EXPOSURES AT DIFFERENT WAVELENGTHS
granted -
WO 2014117863
FORMES POLYMORPHES DE SELS D'ADDITION D'ACIDE DE THIOXANTHÈNE-9-YLIDÈNE-1-MÉTHYLPIPÉRIDINES UTILISÉS COMME COMPOSÉS ANTIMIGRAINEUX
granted
Frequently asked questions
What is US patent 202010004750?
DE 202010004750 (Pharmazeutische oder/und kosmetische Zusammensetzung zur Behandlung der Haut) is held by BIOFRONTERA BIOSCIENCE GMBH [DE]. Status: granted. Granted Oct 11, 2011. Expires Oct 6, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.
Who owns DE 202010004750?
BIOFRONTERA BIOSCIENCE GMBH [DE] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 13 pharmaceutical patents for this assignee.
When does DE 202010004750 expire?
Our index shows an expiration date of Oct 6, 2031 (5 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.